Skip to main content
Erschienen in: AIDS and Behavior 9/2023

16.03.2023 | Original Paper

Injection Drug Use and Sexual Risk Behaviors Among People who Inject Drugs in Ukraine: A Random-Intercept Latent Transition Analysis

verfasst von: John Mark Wiginton, Robert Booth, Lisa A. Eaton, Laramie R. Smith, Cristina Espinosa da Silva, Thomas L. Patterson, Eileen V. Pitpitan

Erschienen in: AIDS and Behavior | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

HIV transmission in Ukraine is driven in part by unsafe injection drug use and sexual risk behaviors among people who inject drugs. We performed a random-intercept latent transition analysis on responses to 9 binary injection drug use and sexual behavior items from 1195 people who inject drugs with negative HIV status enrolled in a clustered randomized clinical trial of a social network intervention in Odessa, Donetsk, and Nikolayev, Ukraine. We identified 5 baseline classes: “Social injection/equipment-sharing” (11.7%), “Social injection” (25.9%), “High-risk collective preparation/splitting” (17.0%), “Collective preparation/splitting” (11.3%), and “Dealer-facilitated injection” (34.1%). After 12 months, intervention participants were more likely to transition to the “Collective preparation/splitting” class, which featured the fewest risk behaviors. Transitioning from the “Collective preparation/splitting” to the “Social injection/equipment-sharing” class was associated with HIV acquisition for control participants. Research to illuminate the stability of these patterns and how they may benefit from uniquely tailored programming to reduce unsafe behaviors is needed.
Literatur
1.
Zurück zum Zitat Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192–207.PubMedCrossRef Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192–207.PubMedCrossRef
2.
Zurück zum Zitat Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet. 2010;376(9737):285–301.PubMedCrossRef Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet. 2010;376(9737):285–301.PubMedCrossRef
3.
Zurück zum Zitat De P, Cox J, Boivin JF, Platt RW, Jolly AM. The importance of social networks in their association to drug equipment sharing among injection drug users: a review. Addiction. 2007;102(11):1730–9.PubMedCrossRef De P, Cox J, Boivin JF, Platt RW, Jolly AM. The importance of social networks in their association to drug equipment sharing among injection drug users: a review. Addiction. 2007;102(11):1730–9.PubMedCrossRef
4.
Zurück zum Zitat Degenhardt L, Charlson F, Stanaway J, Larney S, Alexander LT, Hickman M, et al. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16(12):1385–98.PubMedCrossRef Degenhardt L, Charlson F, Stanaway J, Larney S, Alexander LT, Hickman M, et al. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16(12):1385–98.PubMedCrossRef
5.
Zurück zum Zitat Des Jarlais DC, Feelemyer JP, Modi SN, Arasteh K, Mathers BM, Degenhardt L, et al. Transitions from injection-drug-use-concentrated to self-sustaining heterosexual HIV epidemics: patterns in the international data. PLoS ONE. 2012;7(3): e31227.PubMedPubMedCentralCrossRef Des Jarlais DC, Feelemyer JP, Modi SN, Arasteh K, Mathers BM, Degenhardt L, et al. Transitions from injection-drug-use-concentrated to self-sustaining heterosexual HIV epidemics: patterns in the international data. PLoS ONE. 2012;7(3): e31227.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Rachlis B, Brouwer KC, Mills EJ, Hayes M, Kerr T, Hogg RS. Migration and transmission of blood-borne infections among injection drug users: understanding the epidemiologic bridge. Drug Alcohol Depend. 2007;90(2–3):107–19.PubMedCrossRef Rachlis B, Brouwer KC, Mills EJ, Hayes M, Kerr T, Hogg RS. Migration and transmission of blood-borne infections among injection drug users: understanding the epidemiologic bridge. Drug Alcohol Depend. 2007;90(2–3):107–19.PubMedCrossRef
9.
11.
Zurück zum Zitat Burruano L, Kruglov Y. HIV/AIDS epidemic in Eastern Europe: recent developments in the Russian Federation and Ukraine among women. Gend Med. 2009;6(1):277–89.PubMedCrossRef Burruano L, Kruglov Y. HIV/AIDS epidemic in Eastern Europe: recent developments in the Russian Federation and Ukraine among women. Gend Med. 2009;6(1):277–89.PubMedCrossRef
12.
Zurück zum Zitat Vitek CR, Čakalo JI, Kruglov YV, Dumchev KV, Salyuk TO, Božičević I, et al. Slowing of the HIV epidemic in Ukraine: evidence from case reporting and key population surveys, 2005–2012. PLoS ONE. 2014;9(9): e103657.PubMedPubMedCentralCrossRef Vitek CR, Čakalo JI, Kruglov YV, Dumchev KV, Salyuk TO, Božičević I, et al. Slowing of the HIV epidemic in Ukraine: evidence from case reporting and key population surveys, 2005–2012. PLoS ONE. 2014;9(9): e103657.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Latkin CA. Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users’ networks. Public Health Rep. 1998;113(Suppl 1):151–9.PubMedPubMedCentral Latkin CA. Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users’ networks. Public Health Rep. 1998;113(Suppl 1):151–9.PubMedPubMedCentral
14.
Zurück zum Zitat Theall KP, Sterk CE, Elifson KW, Kidder D. Factors associated with positive HIV serostatus among women who use drugs: continued evidence for expanding factors of influence. Public Health Rep. 2003;118(5):415–24.PubMedPubMedCentralCrossRef Theall KP, Sterk CE, Elifson KW, Kidder D. Factors associated with positive HIV serostatus among women who use drugs: continued evidence for expanding factors of influence. Public Health Rep. 2003;118(5):415–24.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Tobin KE, Kuramoto SJ, Davey-Rothwell MA, Latkin CA. The STEP into Action study: a peer-based, personal risk network-focused HIV prevention intervention with injection drug users in Baltimore, Maryland. Addiction. 2011;106(2):366–75.PubMedCrossRef Tobin KE, Kuramoto SJ, Davey-Rothwell MA, Latkin CA. The STEP into Action study: a peer-based, personal risk network-focused HIV prevention intervention with injection drug users in Baltimore, Maryland. Addiction. 2011;106(2):366–75.PubMedCrossRef
16.
Zurück zum Zitat Neaigus A, Gyarmathy VA, Miller M, Frajzyngier VM, Friedman SR, Des Jarlais DC. Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr. 2006;41(4):493–503.PubMedCrossRef Neaigus A, Gyarmathy VA, Miller M, Frajzyngier VM, Friedman SR, Des Jarlais DC. Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr. 2006;41(4):493–503.PubMedCrossRef
17.
Zurück zum Zitat Ghosh D, Krishnan A, Gibson B, Brown SE, Latkin CA, Altice FL. Social network strategies to address HIV prevention and treatment continuum of care among at-risk and HIV-infected substance users: a systematic scoping review. AIDS Behav. 2017;21(4):1183–207.PubMedPubMedCentralCrossRef Ghosh D, Krishnan A, Gibson B, Brown SE, Latkin CA, Altice FL. Social network strategies to address HIV prevention and treatment continuum of care among at-risk and HIV-infected substance users: a systematic scoping review. AIDS Behav. 2017;21(4):1183–207.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Booth RE, Lehman WE, Latkin CA, Dvoryak S, Brewster JT, Royer MS, et al. Individual and network interventions with injection drug users in 5 Ukraine cities. Am J Public Health. 2011;101(2):336–43.PubMedPubMedCentralCrossRef Booth RE, Lehman WE, Latkin CA, Dvoryak S, Brewster JT, Royer MS, et al. Individual and network interventions with injection drug users in 5 Ukraine cities. Am J Public Health. 2011;101(2):336–43.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Booth RE, Lehman WEK, Latkin CA, Brewster JT, Sinitsyna L, Dvoryak S. Use of a peer leader intervention model to reduce needle-related risk behaviors among drug injectors in Ukraine. J Drug Iss. 2009;39(3):607–25.CrossRef Booth RE, Lehman WEK, Latkin CA, Brewster JT, Sinitsyna L, Dvoryak S. Use of a peer leader intervention model to reduce needle-related risk behaviors among drug injectors in Ukraine. J Drug Iss. 2009;39(3):607–25.CrossRef
20.
Zurück zum Zitat Latkin CA, Donnell D, Metzger D, Sherman S, Aramrattna A, Davis-Vogel A, et al. The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USA. Soc Sci Med. 2009;68(4):740–8.PubMedCrossRef Latkin CA, Donnell D, Metzger D, Sherman S, Aramrattna A, Davis-Vogel A, et al. The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USA. Soc Sci Med. 2009;68(4):740–8.PubMedCrossRef
21.
Zurück zum Zitat Latkin CA, Sherman S, Knowlton A. HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychol. 2003;22(4):332–9.PubMedCrossRef Latkin CA, Sherman S, Knowlton A. HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychol. 2003;22(4):332–9.PubMedCrossRef
22.
Zurück zum Zitat Hoffman IF, Latkin CA, Kukhareva PV, Malov SV, Batluk JV, Shaboltas AV, et al. A peer-educator network HIV prevention intervention among injection drug users: results of a randomized controlled trial in St. Petersburg, Russia. AIDS Behav. 2013;17(7):2510–20.PubMedPubMedCentralCrossRef Hoffman IF, Latkin CA, Kukhareva PV, Malov SV, Batluk JV, Shaboltas AV, et al. A peer-educator network HIV prevention intervention among injection drug users: results of a randomized controlled trial in St. Petersburg, Russia. AIDS Behav. 2013;17(7):2510–20.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Mihailovic A, Tobin K, Latkin C. The influence of a peer-based HIV prevention intervention on conversation about HIV prevention among people who inject drugs in Baltimore, Maryland. AIDS Behav. 2015;19(10):1792–800.PubMedPubMedCentralCrossRef Mihailovic A, Tobin K, Latkin C. The influence of a peer-based HIV prevention intervention on conversation about HIV prevention among people who inject drugs in Baltimore, Maryland. AIDS Behav. 2015;19(10):1792–800.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Booth RE, Davis JM, Dvoryak S, Brewster JT, Lisovska O, Strathdee SA, et al. HIV incidence among people who inject drugs (PWIDs) in Ukraine: results from a clustered randomised trial. Lancet HIV. 2016;3(10):e482–9.PubMedPubMedCentralCrossRef Booth RE, Davis JM, Dvoryak S, Brewster JT, Lisovska O, Strathdee SA, et al. HIV incidence among people who inject drugs (PWIDs) in Ukraine: results from a clustered randomised trial. Lancet HIV. 2016;3(10):e482–9.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Mackesy-Amiti ME, Finnegan L, Ouellet LJ, Golub ET, Hagan H, Hudson SM, et al. Peer-education intervention to reduce injection risk behaviors benefits high-risk young injection drug users: a latent transition analysis of the CIDUS 3/DUIT study. AIDS Behav. 2013;17(6):2075–83.PubMedCrossRef Mackesy-Amiti ME, Finnegan L, Ouellet LJ, Golub ET, Hagan H, Hudson SM, et al. Peer-education intervention to reduce injection risk behaviors benefits high-risk young injection drug users: a latent transition analysis of the CIDUS 3/DUIT study. AIDS Behav. 2013;17(6):2075–83.PubMedCrossRef
26.
Zurück zum Zitat Sharifi H, Mirzazadeh A, Noroozi A, Marshall BD, Farhoudian A, Higgs P, et al. Patterns of HIV risks and related factors among people who inject drugs in Kermanshah, Iran: a latent class analysis. J Psychoactive Drugs. 2017;49(1):69–73.PubMedCrossRef Sharifi H, Mirzazadeh A, Noroozi A, Marshall BD, Farhoudian A, Higgs P, et al. Patterns of HIV risks and related factors among people who inject drugs in Kermanshah, Iran: a latent class analysis. J Psychoactive Drugs. 2017;49(1):69–73.PubMedCrossRef
27.
Zurück zum Zitat Noor SW, Ross MW, Lai D, Risser JM. Use of latent class analysis approach to describe drug and sexual HIV risk patterns among injection drug users in Houston, Texas. AIDS Behav. 2014;18(Suppl 3):276–83.PubMedCrossRef Noor SW, Ross MW, Lai D, Risser JM. Use of latent class analysis approach to describe drug and sexual HIV risk patterns among injection drug users in Houston, Texas. AIDS Behav. 2014;18(Suppl 3):276–83.PubMedCrossRef
28.
Zurück zum Zitat Nylund-Gibson K, Choi AY. Ten frequently asked questions about latent class analysis. Trans Issues Psychol Sci. 2018;4(4):440–61.CrossRef Nylund-Gibson K, Choi AY. Ten frequently asked questions about latent class analysis. Trans Issues Psychol Sci. 2018;4(4):440–61.CrossRef
29.
Zurück zum Zitat Lanza ST, Patrick ME, Maggs JL. Latent transition analysis: benefits of a latent variable approach to modeling transitions in substance use. J Drug Issues. 2010;40(1):93–120.PubMedPubMedCentralCrossRef Lanza ST, Patrick ME, Maggs JL. Latent transition analysis: benefits of a latent variable approach to modeling transitions in substance use. J Drug Issues. 2010;40(1):93–120.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Latkin CA, Forman V, Knowlton A, Sherman S. Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users. Soc Sci Med. 2003;56(3):465–76.PubMedCrossRef Latkin CA, Forman V, Knowlton A, Sherman S. Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users. Soc Sci Med. 2003;56(3):465–76.PubMedCrossRef
32.
Zurück zum Zitat Latkin CA, Hua W, Davey MA. Factors associated with peer HIV prevention outreach in drug-using communities. AIDS Educ Prev. 2004;16(6):499–508.PubMedCrossRef Latkin CA, Hua W, Davey MA. Factors associated with peer HIV prevention outreach in drug-using communities. AIDS Educ Prev. 2004;16(6):499–508.PubMedCrossRef
34.
Zurück zum Zitat Muthén B, Asparouhov T. Latent transition analysis with random intercepts (RI-LTA). Psychol Methods 2020 11/23. Muthén B, Asparouhov T. Latent transition analysis with random intercepts (RI-LTA). Psychol Methods 2020 11/23.
35.
Zurück zum Zitat Collins LM, Schafer JL, Kam CM. A comparison of inclusive and restrictive strategies in modern missing data procedures. Psychol Methods. 2001;6(4):330–51.PubMedCrossRef Collins LM, Schafer JL, Kam CM. A comparison of inclusive and restrictive strategies in modern missing data procedures. Psychol Methods. 2001;6(4):330–51.PubMedCrossRef
36.
Zurück zum Zitat Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods. 2002;7(2):147–77.PubMedCrossRef Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods. 2002;7(2):147–77.PubMedCrossRef
38.
Zurück zum Zitat StatCorp LLC. Stata statistical software, release 15. 2017. College Station, TX: StataCorp LLC. StatCorp LLC. Stata statistical software, release 15. 2017. College Station, TX: StataCorp LLC.
39.
Zurück zum Zitat Muthen B, Muthen L. Mplus User's Guide (8th ed.). 1998–2018;8. Los Angeles, CA: Muthen & Muthen. Muthen B, Muthen L. Mplus User's Guide (8th ed.). 1998–2018;8. Los Angeles, CA: Muthen & Muthen.
40.
Zurück zum Zitat Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J. Estimating per-act HIV transmission risk: a systematic review. AIDS. 2014;28(10):1509–19.PubMedCrossRef Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J. Estimating per-act HIV transmission risk: a systematic review. AIDS. 2014;28(10):1509–19.PubMedCrossRef
41.
Zurück zum Zitat Booth RE, Kennedy J, Brewster T, Semerik O. Drug injectors and dealers in Odessa, Ukraine. J Psychoactive Drugs. 2003;35(4):419–26.PubMedCrossRef Booth RE, Kennedy J, Brewster T, Semerik O. Drug injectors and dealers in Odessa, Ukraine. J Psychoactive Drugs. 2003;35(4):419–26.PubMedCrossRef
42.
Zurück zum Zitat Booth RE, Kwiatkowski CF, Brewster JT, Sinitsyna L, Dvoryak S. Predictors of HIV sero-status among drug injectors at three Ukraine sites. AIDS. 2006;20(17):2217–23.PubMedCrossRef Booth RE, Kwiatkowski CF, Brewster JT, Sinitsyna L, Dvoryak S. Predictors of HIV sero-status among drug injectors at three Ukraine sites. AIDS. 2006;20(17):2217–23.PubMedCrossRef
43.
Zurück zum Zitat Makarenko I, Ompad DC, Sazonova Y, Saliuk T, DeHovitz J, Gensburg L. Trends in injection risk behaviors among people who inject drugs and the impact of harm reduction programs in Ukraine, 2007–2013. J Urban Health. 2017;94(1):104–14.PubMedPubMedCentralCrossRef Makarenko I, Ompad DC, Sazonova Y, Saliuk T, DeHovitz J, Gensburg L. Trends in injection risk behaviors among people who inject drugs and the impact of harm reduction programs in Ukraine, 2007–2013. J Urban Health. 2017;94(1):104–14.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Mazhnaya A, Kiriazova T, Chernova O, Tobin K, Owczarzak J. “Now it is mostly done through stashes, to do it in person one has to trust you”: Understanding the retail injection drug market in Dnipro. Ukraine Int J Drug Policy. 2021;87: 102988.PubMedCrossRef Mazhnaya A, Kiriazova T, Chernova O, Tobin K, Owczarzak J. “Now it is mostly done through stashes, to do it in person one has to trust you”: Understanding the retail injection drug market in Dnipro. Ukraine Int J Drug Policy. 2021;87: 102988.PubMedCrossRef
45.
Zurück zum Zitat Dejong W, Wolf RC, Austin SB. U.S. Federally funded television public service announcements (PSAs) to prevent HIV/AIDS: a content analysis. J Health Commun. 2001;6(3):249–63.PubMedCrossRef Dejong W, Wolf RC, Austin SB. U.S. Federally funded television public service announcements (PSAs) to prevent HIV/AIDS: a content analysis. J Health Commun. 2001;6(3):249–63.PubMedCrossRef
46.
Zurück zum Zitat Sinding SW. Does “CNN” (condoms, needles and negotiation) work better than “ABC” (abstinence, being faithful and condom use) in attacking the AIDS epidemic? Int Fam Plan Perspect. 2005;31(1):38–40.PubMedCrossRef Sinding SW. Does “CNN” (condoms, needles and negotiation) work better than “ABC” (abstinence, being faithful and condom use) in attacking the AIDS epidemic? Int Fam Plan Perspect. 2005;31(1):38–40.PubMedCrossRef
47.
48.
49.
Zurück zum Zitat Bryant J, Brener L, Hull P, Treloar C. Needle sharing in regular sexual relationships: an examination of serodiscordance, drug using practices, and the gendered character of injecting. Drug Alcohol Depend. 2010;107(2–3):182–7.PubMedCrossRef Bryant J, Brener L, Hull P, Treloar C. Needle sharing in regular sexual relationships: an examination of serodiscordance, drug using practices, and the gendered character of injecting. Drug Alcohol Depend. 2010;107(2–3):182–7.PubMedCrossRef
50.
Zurück zum Zitat Rance J, Rhodes T, Fraser S, Bryant J, Treloar C. Practices of partnership: negotiated safety among couples who inject drugs. Health (London). 2018;22(1):3–19.PubMedCrossRef Rance J, Rhodes T, Fraser S, Bryant J, Treloar C. Practices of partnership: negotiated safety among couples who inject drugs. Health (London). 2018;22(1):3–19.PubMedCrossRef
51.
Zurück zum Zitat Deryabina AP, Patnaik P, El-Sadr WM. Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan. Harm Reduct J. 2019;16(1):1-018-0274–2.CrossRef Deryabina AP, Patnaik P, El-Sadr WM. Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan. Harm Reduct J. 2019;16(1):1-018-0274–2.CrossRef
52.
Zurück zum Zitat Davlidova S, Haley-Johnson Z, Nyhan K, Farooq A, Vermund SH, Ali S. Prevalence of HIV, HCV and HBV in Central Asia and the Caucasus: a systematic review. Int J Infect Dis. 2021;104:510–25.PubMedCrossRef Davlidova S, Haley-Johnson Z, Nyhan K, Farooq A, Vermund SH, Ali S. Prevalence of HIV, HCV and HBV in Central Asia and the Caucasus: a systematic review. Int J Infect Dis. 2021;104:510–25.PubMedCrossRef
54.
Zurück zum Zitat Uusküla A, Raag M, Folch C, Prasad L, Karnite A, van Veen MG, et al. Self-reported testing, HIV status and associated risk behaviours among people who inject drugs in Europe: important differences between East and West. AIDS. 2014;28(11):1657–64.PubMedCrossRef Uusküla A, Raag M, Folch C, Prasad L, Karnite A, van Veen MG, et al. Self-reported testing, HIV status and associated risk behaviours among people who inject drugs in Europe: important differences between East and West. AIDS. 2014;28(11):1657–64.PubMedCrossRef
55.
Zurück zum Zitat Tran LT, Peacock A, Colledge S, Memedovic S, Grebely J, Leung J, et al. Injecting risk behaviours amongst people who inject drugs: a global multi-stage systematic review and meta-analysis. Int J Drug Policy. 2020;84: 102866.PubMedCrossRef Tran LT, Peacock A, Colledge S, Memedovic S, Grebely J, Leung J, et al. Injecting risk behaviours amongst people who inject drugs: a global multi-stage systematic review and meta-analysis. Int J Drug Policy. 2020;84: 102866.PubMedCrossRef
56.
Zurück zum Zitat Otiashvili D, Latypov A, Kirtadze I, Ibragimov U, Zule W. Drug preparation, injection, and sharing practices in Tajikistan: a qualitative study in Kulob and Khorog. Subst Abuse Treat Prev Policy. 2016;11(1):21.PubMedPubMedCentralCrossRef Otiashvili D, Latypov A, Kirtadze I, Ibragimov U, Zule W. Drug preparation, injection, and sharing practices in Tajikistan: a qualitative study in Kulob and Khorog. Subst Abuse Treat Prev Policy. 2016;11(1):21.PubMedPubMedCentralCrossRef
57.
Zurück zum Zitat Dumchev KV, Soldyshev R, Qian HZ, Zezyulin OO, Chandler SD, Slobodyanyuk P, et al. HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine: a cross-sectional survey. Harm Reduct J. 2009;23(6):23-7517-6–23. Dumchev KV, Soldyshev R, Qian HZ, Zezyulin OO, Chandler SD, Slobodyanyuk P, et al. HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine: a cross-sectional survey. Harm Reduct J. 2009;23(6):23-7517-6–23.
58.
Zurück zum Zitat Kruse GR, Barbour R, Heimer R, Shaboltas AV, Toussova OV, Hoffman IF, et al. Drug choice, spatial distribution, HIV risk, and HIV prevalence among injection drug users in St. Petersburg, Russia. Harm Reduct J. 2009;6:22-7517-6–22.CrossRef Kruse GR, Barbour R, Heimer R, Shaboltas AV, Toussova OV, Hoffman IF, et al. Drug choice, spatial distribution, HIV risk, and HIV prevalence among injection drug users in St. Petersburg, Russia. Harm Reduct J. 2009;6:22-7517-6–22.CrossRef
59.
Zurück zum Zitat Sazonova Y, Kulchynska R, Sereda Y, Azarskova M, Novak Y, Saliuk T, et al. HIV treatment cascade among people who inject drugs in Ukraine. PLoS ONE. 2020;15(12): e0244572.PubMedPubMedCentralCrossRef Sazonova Y, Kulchynska R, Sereda Y, Azarskova M, Novak Y, Saliuk T, et al. HIV treatment cascade among people who inject drugs in Ukraine. PLoS ONE. 2020;15(12): e0244572.PubMedPubMedCentralCrossRef
60.
Zurück zum Zitat Bojko MJ, Mazhnaya A, Makarenko I, Marcus R, Dvoriak S, Islam Z, et al. “Bureaucracy & beliefs”: assessing the barriers to accessing opioid substitution therapy by people who inject drugs in Ukraine. Drugs (Abingdon Engl). 2015;22(3):255–62.PubMed Bojko MJ, Mazhnaya A, Makarenko I, Marcus R, Dvoriak S, Islam Z, et al. “Bureaucracy & beliefs”: assessing the barriers to accessing opioid substitution therapy by people who inject drugs in Ukraine. Drugs (Abingdon Engl). 2015;22(3):255–62.PubMed
61.
Zurück zum Zitat Lee JO, Yoon Y, Idrisov B, Kiriazova T, Makarenko O, Sereda Y, et al. Violence, HIV risks, and polysubstance use among HIV-positive people who inject drugs in Ukraine. AIDS Behav. 2021;25(7):2120–30.PubMedPubMedCentralCrossRef Lee JO, Yoon Y, Idrisov B, Kiriazova T, Makarenko O, Sereda Y, et al. Violence, HIV risks, and polysubstance use among HIV-positive people who inject drugs in Ukraine. AIDS Behav. 2021;25(7):2120–30.PubMedPubMedCentralCrossRef
62.
Zurück zum Zitat Corsi KF, Dvoryak S, Garver-Apgar C, Davis JM, Brewster JT, Lisovska O, et al. Gender differences between predictors of HIV status among PWID in Ukraine. Drug Alcohol Depend. 2014;1(138):103–8.CrossRef Corsi KF, Dvoryak S, Garver-Apgar C, Davis JM, Brewster JT, Lisovska O, et al. Gender differences between predictors of HIV status among PWID in Ukraine. Drug Alcohol Depend. 2014;1(138):103–8.CrossRef
63.
Zurück zum Zitat Mazhnaya A, Tobin KE, Owczarzak J. Association between injection in public places and HIV/HCV risk behavior among people who use drugs in Ukraine. Drug Alcohol Depend. 2018;1(189):125–30.CrossRef Mazhnaya A, Tobin KE, Owczarzak J. Association between injection in public places and HIV/HCV risk behavior among people who use drugs in Ukraine. Drug Alcohol Depend. 2018;1(189):125–30.CrossRef
64.
Zurück zum Zitat Owczarzak J, Nguyen TQ, Mazhnaya A, Phillips SD, Filippova O, Alpatova P, et al. Outcome evaluation of a “common factors” approach to develop culturally tailored HIV prevention interventions for people who inject drugs. Drug Alcohol Depend. 2019;1(199):18–26.CrossRef Owczarzak J, Nguyen TQ, Mazhnaya A, Phillips SD, Filippova O, Alpatova P, et al. Outcome evaluation of a “common factors” approach to develop culturally tailored HIV prevention interventions for people who inject drugs. Drug Alcohol Depend. 2019;1(199):18–26.CrossRef
65.
Zurück zum Zitat Kuzin I, Martzynovska V, Antonenko Z. HIV infection in Ukraine. Public Health Center of the Ministry of Health of Ukraine. 2020; Newsletter No. 51. Kuzin I, Martzynovska V, Antonenko Z. HIV infection in Ukraine. Public Health Center of the Ministry of Health of Ukraine. 2020; Newsletter No. 51.
67.
Zurück zum Zitat Meteliuk A, Galvez de Leon, Samy J, Madden LM, Pykalo I, Fomenko T, Filippovych M, et al. Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine. J Subst Abuse Treat. 2021;121:108164.PubMedCrossRef Meteliuk A, Galvez de Leon, Samy J, Madden LM, Pykalo I, Fomenko T, Filippovych M, et al. Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine. J Subst Abuse Treat. 2021;121:108164.PubMedCrossRef
69.
Zurück zum Zitat Essar MY, Matiashova L, Tsagkaris C, Vladychuk V, Head M. Infectious diseases amidst a humanitarian crisis in Ukraine: a rising concern. Ann Med Surg (Lond). 2022;3(78): 103950. Essar MY, Matiashova L, Tsagkaris C, Vladychuk V, Head M. Infectious diseases amidst a humanitarian crisis in Ukraine: a rising concern. Ann Med Surg (Lond). 2022;3(78): 103950.
70.
Zurück zum Zitat Vasylyeva TI, Smyrnov P, Strathdee S, Friedman SR. Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks. J Int AIDS Soc. 2020;23(7): e25583.PubMedPubMedCentralCrossRef Vasylyeva TI, Smyrnov P, Strathdee S, Friedman SR. Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks. J Int AIDS Soc. 2020;23(7): e25583.PubMedPubMedCentralCrossRef
71.
Zurück zum Zitat Filippovych S. Impact of armed conflicts and warfare on opioid substitution treatment in Ukraine: responding to emergency needs. Int J Drug Policy. 2015;26(1):3–5.PubMedCrossRef Filippovych S. Impact of armed conflicts and warfare on opioid substitution treatment in Ukraine: responding to emergency needs. Int J Drug Policy. 2015;26(1):3–5.PubMedCrossRef
72.
Zurück zum Zitat Kazatchkine M. Russia’s ban on methadone for drug users in Crimea will worsen the HIV/AIDS epidemic and risk public health. BMJ. 2014;8(348): g3118.CrossRef Kazatchkine M. Russia’s ban on methadone for drug users in Crimea will worsen the HIV/AIDS epidemic and risk public health. BMJ. 2014;8(348): g3118.CrossRef
73.
Zurück zum Zitat Vasylyeva TI, Liulchuk M, Friedman SR, Sazonova I, Faria NR, Katzourakis A, et al. Molecular epidemiology reveals the role of war in the spread of HIV in Ukraine. Proc Natl Acad Sci USA. 2018;115(5):1051–6.PubMedPubMedCentralCrossRef Vasylyeva TI, Liulchuk M, Friedman SR, Sazonova I, Faria NR, Katzourakis A, et al. Molecular epidemiology reveals the role of war in the spread of HIV in Ukraine. Proc Natl Acad Sci USA. 2018;115(5):1051–6.PubMedPubMedCentralCrossRef
74.
Zurück zum Zitat Altice FL, Bromberg DJ, Dvoriak S, Meteliuk A, Pykalo I, Islam Z, et al. Extending a lifeline to people with HIV and opioid use disorder during the war in Ukraine. Lancet Public Health. 2022;7(5):e482–4.PubMedPubMedCentralCrossRef Altice FL, Bromberg DJ, Dvoriak S, Meteliuk A, Pykalo I, Islam Z, et al. Extending a lifeline to people with HIV and opioid use disorder during the war in Ukraine. Lancet Public Health. 2022;7(5):e482–4.PubMedPubMedCentralCrossRef
75.
Zurück zum Zitat Kai J, Parczewski M, van de Vijver D. The war refugees from Ukraine: an HIV epidemic is fleeing as well. AIDS. 2022;36(12):1745–6.CrossRef Kai J, Parczewski M, van de Vijver D. The war refugees from Ukraine: an HIV epidemic is fleeing as well. AIDS. 2022;36(12):1745–6.CrossRef
76.
Zurück zum Zitat Kazatchkine M. Ukrainian war: an economic crisis in Eastern Europe and Central Asia will lead to a health crisis. BMJ. 2022;24(376): o793.CrossRef Kazatchkine M. Ukrainian war: an economic crisis in Eastern Europe and Central Asia will lead to a health crisis. BMJ. 2022;24(376): o793.CrossRef
Metadaten
Titel
Injection Drug Use and Sexual Risk Behaviors Among People who Inject Drugs in Ukraine: A Random-Intercept Latent Transition Analysis
verfasst von
John Mark Wiginton
Robert Booth
Lisa A. Eaton
Laramie R. Smith
Cristina Espinosa da Silva
Thomas L. Patterson
Eileen V. Pitpitan
Publikationsdatum
16.03.2023
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 9/2023
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-023-04024-0

Weitere Artikel der Ausgabe 9/2023

AIDS and Behavior 9/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.